The Oncology Institute(TOI) GlobeNewswire·2025-02-26 21:57Core Insights - Topicus.com Inc. reported strong financial results for Q4 and the full year 2024, with total revenue reaching €364.9 million for the quarter and €1,294.9 million for the year, marking increases of 18% and 15% respectively compared to 2023 [5][8] - The company's net income for Q4 2024 was €56.2 million, a 32% increase from €42.5 million in Q4 2023, while the annual net income rose to €149.5 million, up 30% from €115.4 million in 2023 [6][8] - Cash flows from operations (CFO) also saw significant growth, increasing by 28% to €79.6 million in Q4 and by 41% to €347.6 million for the full year [7][8] Financial Performance - Total revenue for Q4 2024 was €364.9 million, up from €309.7 million in Q4 2023, driven by acquisitions and organic growth of 5% [5][8] - For the full year 2024, total revenues were €1,294.9 million, compared to €1,125.0 million in 2023, with organic growth also at 5% [5][8] - Net income for Q4 2024 was €56.2 million, translating to €0.40 per share, compared to €42.5 million (€0.31 per share) in Q4 2023 [6][8] - Annual net income increased to €149.5 million (€1.11 per share) from €115.4 million (€0.88 per share) in 2023 [6][8] Cash Flow and Acquisitions - CFO for Q4 2024 increased to €79.6 million from €62.4 million in Q4 2023, representing a 28% growth [7][8] - For the full year, CFO rose to €347.6 million from €246.6 million, a 41% increase [7][8] - Free cash flow available to shareholders (FCFA2S) for Q4 2024 was €36.6 million, up 27% from €28.9 million in Q4 2023, and for the full year, it increased to €177.4 million from €123.4 million, a 44% rise [9][8] - The company completed acquisitions for a total cash consideration of €153.4 million in 2024, including holdbacks and contingent considerations [8] Balance Sheet Highlights - As of December 31, 2024, total assets were €1,535.9 million, up from €1,432.8 million in 2023 [15][16] - Current assets included cash of €206.2 million and accounts receivable of €142.8 million [15] - Total liabilities increased to €1,004.5 million from €840.3 million in 2023, with current liabilities including a revolving credit facility of €225.7 million [16] Shareholder Returns - The company paid dividends totaling €127.6 million to shareholders in 2024 [26] - Retained earnings as of December 31, 2024, were €266.3 million, down from €297.4 million in 2023 [21][23]